JCI Insight · 2020 · 12 citations · 62 references
Life SciencesGeneticsHematologyCancer GeneticsCytogeneticsStem Cell BiologyBone Marrow Failure SyndromesHematologic MalignanciesHematopoietic DevelopmentHematopoietic NeoplasmsHematopoietic Stem Cell BiologyHematopoietic Stem CellsAcute Myeloid Leukemia ProgressionBone Marrow - Derived CellsCancer Mutation Signature AnalysisCancer Mutation SignaturesInherited Bone Marrow Failure SyndromesLeukemia RiskShwachman-diamond SyndromeTargeted Sequencing
Inherited bone marrow failure syndromes, such as Fanconi anemia (FA) and Shwachman-Diamond syndrome (SDS), feature progressive cytopenia and a risk of acute myeloid leukemia (AML). Using deep phenotypic analysis of early progenitors in FA/SDS bone marrow samples, we revealed selective survival of progenitors that phenotypically resembled granulocyte-monocyte progenitors (GMP). Whole-exome and targeted sequencing of GMP-like cells in leukemia-free patients revealed a higher mutation load than in healthy controls and molecular changes that are characteristic of AML: increased G>A/C>T variants, decreased A>G/T>C variants, increased trinucleotide mutations at Xp(C>T)pT, and decreased mutation rates at Xp(C>T)pG sites compared with other Xp(C>T)pX sites and enrichment for Cancer Signature 1 (X indicates any nucleotide). Potential preleukemic targets in the GMP-like cells from patients with FA/SDS included SYNE1, DST, HUWE1, LRP2, NOTCH2, and TP53. Serial analysis of GMPs from an SDS patient who progressed to leukemia revealed a gradual increase in mutational burden, enrichment of G>A/C>T signature, and emergence of new clones. Interestingly, the molecular signature of marrow cells from 2 FA/SDS patients with leukemia was similar to that of FA/SDS patients without transformation. The predicted founding clones in SDS-derived AML harbored mutations in several genes, including TP53, while in FA-derived AML the mutated genes included ARID1B and SFPQ. We describe an architectural change in the hematopoietic hierarchy of FA/SDS with remarkable preservation of GMP-like populations harboring unique mutation signatures. GMP-like cells might represent a cellular reservoir for clonal evolution.
62
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov, Serena Nik‐Zainal, David C. Wedge et al. · Nature · 2013 · 10.1K citations · Full text
Medicine, Cancer Biology, Oncology +14
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller, Rebecca L. Siegel, Chun Chieh Lin et al. · CA A Cancer Journal for Clinicians · 2016 · 6.2K citations · Full text
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis, Li Ding, David J. Dooling et al. · New England Journal of Medicine · 2009 · 2.2K citations · Full text
Mutational Processes Molding the Genomes of 21 Breast Cancers
Serena Nik‐Zainal, Ludmil B. Alexandrov, David C. Wedge et al. · Cell · 2012 · 2K citations · Full text
Life Sciences, Genetics, Oncology +14
The Origin and Evolution of Mutations in Acute Myeloid Leukemia
John S. Welch, Timothy J. Ley, Daniel C. Link et al. · Cell · 2012 · 1.6K citations · Full text